Literature DB >> 31110312

Toll-like receptors TLR2 and TLR4 block the replication of pancreatic β cells in diet-induced obesity.

Yewei Ji1,2, Shengyi Sun2,3, Neha Shrestha1, Laurel B Darragh2,4, Jun Shirakawa5, Yuan Xing6, Yi He6, Bethany A Carboneau7, Hana Kim2,8, Duo An9, Minglin Ma9, Jose Oberholzer6, Scott A Soleimanpour10, Maureen Gannon7, Chengyang Liu11, Ali Naji11, Rohit N Kulkarni5, Yong Wang6, Sander Kersten2,12, Ling Qi13,14,15.   

Abstract

Consumption of a high-energy Western diet triggers mild adaptive β cell proliferation to compensate for peripheral insulin resistance; however, the underlying molecular mechanism remains unclear. In the present study we show that the toll-like receptors TLR2 and TLR4 inhibited the diet-induced replication of β cells in mice and humans. The combined, but not the individual, loss of TLR2 and TLR4 increased the replication of β cells, but not that of α cells, leading to enlarged β cell area and hyperinsulinemia in diet-induced obesity. Loss of TLR2 and TLR4 increased the nuclear abundance of the cell cycle regulators cyclin D2 and Cdk4 in a manner dependent on the signaling mediator Erk. These data reveal a regulatory mechanism controlling the proliferation of β cells in diet-induced obesity and suggest that selective targeting of the TLR2/TLR4 pathways may reverse β cell failure in patients with diabetes.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31110312      PMCID: PMC6531334          DOI: 10.1038/s41590-019-0396-z

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  55 in total

1.  The ER-associated degradation adaptor protein Sel1L regulates LPL secretion and lipid metabolism.

Authors:  Haibo Sha; Shengyi Sun; Adam B Francisco; Nicole Ehrhardt; Zhen Xue; Lei Liu; Peter Lawrence; Frits Mattijssen; Robert D Guber; Muhammad S Panhwar; J Thomas Brenna; Hang Shi; Bingzhong Xue; Sander Kersten; André Bensadoun; Miklós Péterfy; Qiaoming Long; Ling Qi
Journal:  Cell Metab       Date:  2014-07-24       Impact factor: 27.287

2.  S961, an insulin receptor antagonist causes hyperinsulinemia, insulin-resistance and depletion of energy stores in rats.

Authors:  Ajit Vikram; Gopabandhu Jena
Journal:  Biochem Biophys Res Commun       Date:  2010-06-19       Impact factor: 3.575

3.  Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth.

Authors:  Jake A Kushner; Maria A Ciemerych; Ewa Sicinska; Lynn M Wartschow; Monica Teta; Simon Y Long; Piotr Sicinski; Morris F White
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

4.  Very slow turnover of beta-cells in aged adult mice.

Authors:  Monica Teta; Simon Y Long; Lynn M Wartschow; Matthew M Rankin; Jake A Kushner
Journal:  Diabetes       Date:  2005-09       Impact factor: 9.461

5.  Microfluidic perifusion and imaging device for multi-parametric islet function assessment.

Authors:  Adeola F Adewola; Dongyoung Lee; Tricia Harvat; Javeed Mohammed; David T Eddington; Jose Oberholzer; Yong Wang
Journal:  Biomed Microdevices       Date:  2010-06       Impact factor: 2.838

6.  Adaptive β-cell proliferation increases early in high-fat feeding in mice, concurrent with metabolic changes, with induction of islet cyclin D2 expression.

Authors:  Rachel E Stamateris; Rohit B Sharma; Douglas A Hollern; Laura C Alonso
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-05-14       Impact factor: 4.310

7.  Recovery from diabetes in mice by beta cell regeneration.

Authors:  Tomer Nir; Douglas A Melton; Yuval Dor
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

8.  Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance.

Authors:  Terumasa Okada; Chong Wee Liew; Jiang Hu; Charlotte Hinault; M Dodson Michael; Jan Krtzfeldt; Catherine Yin; Martin Holzenberger; Markus Stoffel; Rohit N Kulkarni
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-06       Impact factor: 11.205

9.  Regulation of pancreatic beta cell mass by neuronal signals from the liver.

Authors:  Junta Imai; Hideki Katagiri; Tetsuya Yamada; Yasushi Ishigaki; Toshinobu Suzuki; Hirohito Kudo; Kenji Uno; Yutaka Hasegawa; Junhong Gao; Keizo Kaneko; Hisamitsu Ishihara; Akira Niijima; Masamitsu Nakazato; Tomoichiro Asano; Yasuhiko Minokoshi; Yoshitomo Oka
Journal:  Science       Date:  2008-11-21       Impact factor: 47.728

10.  National Institutes of Health-Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing Facilities.

Authors:  Camillo Ricordi; Julia S Goldstein; A N Balamurugan; Gregory L Szot; Tatsuya Kin; Chengyang Liu; Christine W Czarniecki; Barbara Barbaro; Nancy D Bridges; Jose Cano; William R Clarke; Thomas L Eggerman; Lawrence G Hunsicker; Dixon B Kaufman; Aisha Khan; David-Erick Lafontant; Elina Linetsky; Xunrong Luo; James F Markmann; Ali Naji; Olle Korsgren; Jose Oberholzer; Nicole A Turgeon; Daniel Brandhorst; Xiaojuan Chen; Andrew S Friberg; Ji Lei; Ling-Jia Wang; Joshua J Wilhelm; Jamie Willits; Xiaomin Zhang; Bernhard J Hering; Andrew M Posselt; Peter G Stock; A M James Shapiro; Xiaojuan Chen
Journal:  Diabetes       Date:  2016-07-27       Impact factor: 9.461

View more
  19 in total

1.  Sel1L-Hrd1 ER-associated degradation maintains β cell identity via TGF-β signaling.

Authors:  Neha Shrestha; Tongyu Liu; Yewei Ji; Rachel B Reinert; Mauricio Torres; Xin Li; Maria Zhang; Chih-Hang Anthony Tang; Chih-Chi Andrew Hu; Chengyang Liu; Ali Naji; Ming Liu; Jiandie D Lin; Sander Kersten; Peter Arvan; Ling Qi
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

Review 2.  Translational research on human pancreatic β-cell mass expansion for the treatment of diabetes.

Authors:  Jun Shirakawa
Journal:  Diabetol Int       Date:  2021-08-17

Review 3.  The Structure Basis of Phytochemicals as Metabolic Signals for Combating Obesity.

Authors:  Xiaoping Li; Liufeng Zheng; Bing Zhang; Ze-Yuan Deng; Ting Luo
Journal:  Front Nutr       Date:  2022-06-13

4.  mPGES-2 blockade antagonizes β-cell senescence to ameliorate diabetes by acting on NR4A1.

Authors:  Dandan Zhong; Zhikang Wan; Jie Cai; Lingling Quan; Rumeng Zhang; Tian Teng; Hang Gao; Chenyu Fan; Meng Wang; Dong Guo; Hongxing Zhang; Zhanjun Jia; Ying Sun
Journal:  Nat Metab       Date:  2022-02-28

Review 5.  Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications.

Authors:  Jun Ren; Ne N Wu; Shuyi Wang; James R Sowers; Yingmei Zhang
Journal:  Physiol Rev       Date:  2021-05-05       Impact factor: 37.312

Review 6.  The Human Islet: Mini-Organ With Mega-Impact.

Authors:  John T Walker; Diane C Saunders; Marcela Brissova; Alvin C Powers
Journal:  Endocr Rev       Date:  2021-09-28       Impact factor: 25.261

Review 7.  Islet Inflammation and β Cell Dysfunction in Type 2 Diabetes.

Authors:  Joyceline Cuenco; Elise Dalmas
Journal:  Handb Exp Pharmacol       Date:  2022

8.  TRPM7 is a crucial regulator of pancreatic endocrine development and high-fat-diet-induced β-cell proliferation.

Authors:  Molly K Altman; Charles M Schaub; Prasanna K Dadi; Matthew T Dickerson; Karolina E Zaborska; Arya Y Nakhe; Sarah M Graff; Thomas J Galletta; Gautami Amarnath; Ariel S Thorson; Guoqiang Gu; David A Jacobson
Journal:  Development       Date:  2021-08-16       Impact factor: 6.862

9.  Macrophage-associated pro-inflammatory state in human islets from obese individuals.

Authors:  Wei He; Ting Yuan; Kathrin Maedler
Journal:  Nutr Diabetes       Date:  2019-12-02       Impact factor: 5.097

Review 10.  Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes.

Authors:  Torsten P M Scheithauer; Elena Rampanelli; Max Nieuwdorp; Bruce A Vallance; C Bruce Verchere; Daniël H van Raalte; Hilde Herrema
Journal:  Front Immunol       Date:  2020-10-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.